Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Operational Update June 4, 2025 Next Post Mali Court Adjourns Barrick’s Gold Complex Hearing Over Deepening Taxes, Control Dispute June 4, 2025 Related Posts Group Eleven Drills Best Hole Yet at Ballywire: 39.7m of 9.5% Zn+Pb, 131 g/t Ag and 0.27% Cu, incl. 5.6m of 16.6% Zn+Pb, 370 g/t Ag and 0.86% Cu July 3, 2025 Aurum Resources July 3, 2025 Sun Summit Minerals July 3, 2025
Group Eleven Drills Best Hole Yet at Ballywire: 39.7m of 9.5% Zn+Pb, 131 g/t Ag and 0.27% Cu, incl. 5.6m of 16.6% Zn+Pb, 370 g/t Ag and 0.86% Cu July 3, 2025
